###### 

Adverse events

  AEs                                          All patients (N = 875); N (%)   Cohort 1 (N = 117); N (%)   Cohort 2 (N = 116); N (%)   Cohort 3 (N = 235); N (%)   Cohort 4 (N = 407); N (%)
  -------------------------------------------- ------------------------------- --------------------------- --------------------------- --------------------------- ---------------------------
  One or more AEs                              317 (36.2)                      47 (40.2)                   54 (46.6)                   107 (45.5)                  108 (26.5)
  One or more ADRs                             39 (4.5)                        12 (10.3)                   8 (6.9)                     9 (3.8)                     10 (2.5)
  One or more serious AEs                      105 (12.0)                      19 (16.2)                   16 (13.8)                   26 (11.1)                   43 (10.6)
  Death                                        26 (3.0)                        3 (2.6)                     4 (3.4)                     10 (4.3)                    9 (2.2)
  Darunavir treatment stopped because of AEs   26 (3.0)                        8 (6.8)                     6 (5.2)                     3 (1.3)                     9 (2.2)
  AE Description                                                                                                                                                   
  Rash                                         10 (1.1)                        4 (3.4)                     4 (3.4)                     2 (0.9)                     0
  Diarrhoea                                    24 (2.7)                        3 (2.6)                     4 (3.4)                     8 (3.4)                     9 (2.2)
  Hypertension                                 15 (1.7)                        1 (0.9)                     2 (1.7)                     10 (4.3)                    2 (0.5)
  Hepatic enzymes increased                    10 (1.1)                        4 (3.4)                     1 (0.9)                     3 (1.3)                     2 (0.5)
  Hypercholesterolaemia                        18 (2.1)                        2 (1.7)                     2 (1.7)                     8 (3.4)                     6 (1.5)
  Hypertriglyceridemia                         15 (1.7)                        1 (0.9)                     3 (2.5)                     6 (2.6)                     5 (1.2)
  Hyperlipaemia                                11 (1.3)                        5 (4.3)                     1 (0.9)                     2 (0.9)                     3 (0.7)
  Reduced Bone Mineral Density                 23 (2.6)                        1 (0.9)                     3 (2.6)                     10 (4.3)                    9 (2.2)
  Fever                                        14 (1.6)                        6 (5.1)                     0                           5 (2.1)                     3 (0.7)
